Picture of Immuron logo

IMC — Immuron News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Australia's Immuron jumps on increased global sales of Travelan drug

** Shares of Immuron  IMC.AX  rise as much as 22.7% to
A$0.135, set for best day since March 8, if gains hold    
    ** The biopharmaceutical co says global sales of its
gastrointestinal drug Travelan for year till March 2024 were
A$3.6 mln ($2.39 mln), up 154% from pcp
    ** Stock at its highest level since March 11    
    ** Immuron stock up 42.9% YTD, as of last close

    ($1 = 1.5088 Australian dollars)

 (Reporting by Adwitiya Srivastava in Bengaluru)
 ((Adwitiya.Srivastava@thomsonreuters.com;))

Recent news on Immuron

See all news